Old Web
English
Sign In
Acemap
>
authorDetail
>
Neunggyu Park
Neunggyu Park
Medicine
Pathology
in patient
Antibody
first in human
4
Papers
33
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase 1a study results investigating the safety and preliminary efficacy of ABL001 (NOV1501), a bispecific antibody targeting VEGF and DLL4 in metastatic gastrointestinal (GI) cancer.
2019
Journal of Clinical Oncology
Jeeyun Lee
Seung Hoon Kim
Su Jin Lee
Se Hoon Park
Joon Oh Park
Eunsin Ha
Doo-Hong Park
Neunggyu Park
Hoon-Kyo Kim
Sang-Hoon Lee
Weon-Kyoo You
Ho Yeong Lim
Young Suk Park
Won Ki Kang
Show All
Source
Cite
Save
Citations (2)
First-in-human phase I trial of anti-hepatocyte growth factor (HGF) antibody (YYB101) in refractory solid tumor patients: Integrative pathologic-genomic analysis and the final results.
2019
Journal of Clinical Oncology
Jeeyun Lee
Seung Hoon Kim
Do-Hyun Nam
Su Jin Lee
Se Hoon Park
Joon Oh Park
Jeong-Won Lee
Kyoung-Mee Kim
Hukeun Lee
Neunggyu Park
Hoon-Kyo Kim
Song-Jae Lee
Seong-Won Song
Jung Ju Kim
Young Suk Park
Ho Yeong Lim
Won Ki Kang
Show All
Source
Cite
Save
Citations (1)
Pharmacokinetic characteristics of vactosertib, a new activin receptor-like kinase 5 inhibitor, in patients with advanced solid tumors in a first-in-human phase 1 study
2019
Investigational New Drugs
Su Young Jung
Sunjin Hwang
Jeffery M. Clarke
Todd Michael Bauer
Vicki L. Keedy
Hukeun Lee
Neunggyu Park
Seong-Jin Kim
Jangik I. Lee
Show All
Source
Cite
Save
Citations (14)
Association of TGF-β responsive signature with anti-tumor effect of vactosertib, a potent, oral TGF-β receptor type I (TGFBRI) inhibitor in patients with advanced solid tumors.
2018
Journal of Clinical Oncology
Vicki L. Keedy
Todd Michael Bauer
Jeffrey Melson Clarke
Herbert Hurwitz
Insun Baek
Ilho Ha
Chan-Young Ock
Su-Youn Nam
Mina Kim
Neunggyu Park
Jung-Yong Kim
Seong-Jin Kim
Show All
Source
Cite
Save
Citations (16)
1